Shanghai Labway Clinical Laboratory Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -20.15% vs -0.65% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 122.12% vs -853.57% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "342.70",
          "val2": "429.20",
          "chgp": "-20.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.90",
          "val2": "-51.70",
          "chgp": "132.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "2.20",
          "chgp": "-40.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14.00",
          "val2": "-63.30",
          "chgp": "122.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "49.20%",
          "val2": "-185.20%",
          "chgp": "23.44%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 4.06% vs -60.17% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 39.02% vs -121.88% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,739.40",
          "val2": "1,671.60",
          "chgp": "4.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "39.70",
          "val2": "-72.10",
          "chgp": "155.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "11.00",
          "val2": "8.50",
          "chgp": "29.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-45.30",
          "val2": "-11.10",
          "chgp": "-308.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-98.60",
          "val2": "-161.70",
          "chgp": "39.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-36.70%",
          "val2": "-93.00%",
          "chgp": "5.63%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

342.70

429.20

-20.15%

Operating Profit (PBDIT) excl Other Income

16.90

-51.70

132.69%

Interest

1.30

2.20

-40.91%

Exceptional Items

0.00

0.00

Consolidate Net Profit

14.00

-63.30

122.12%

Operating Profit Margin (Excl OI)

49.20%

-185.20%

23.44%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is -20.15% vs -0.65% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 122.12% vs -853.57% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,739.40

1,671.60

4.06%

Operating Profit (PBDIT) excl Other Income

39.70

-72.10

155.06%

Interest

11.00

8.50

29.41%

Exceptional Items

-45.30

-11.10

-308.11%

Consolidate Net Profit

-98.60

-161.70

39.02%

Operating Profit Margin (Excl OI)

-36.70%

-93.00%

5.63%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 4.06% vs -60.17% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 39.02% vs -121.88% in Dec 2023

All Annual Results